(EMAILWIRE.COM, August 31, 2018 ) The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022. Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics

Objectives of the Study

To define, describe, and segment the global infectious disease diagnostics (IDD) market by product & service, technology, disease type, end user, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, and opportunities)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global infectious disease diagnostics market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
To profile the key players in the market and comprehensively analyze their market positions and core competencies
To track and analyze competitive developments such as acquisitions, product launches and approvals, expansions, and other developments in the market

Research Methodology

Both, top-down and bottom-up approaches were used to validate the size of the global infectious disease diagnostics market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market presence was studied through primary and secondary research. Secondary sources include annual reports, press releases, and investor presentations of companies; white papers; medical journals; certified publications; articles from recognized authors; gold standard and silver standard websites; directories; and databases. Whereas, primary research included extensive interviews with key opinion leaders such as CEOs, vice presidents, directors, marketing executives, and related key executives from various companies. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Get Free Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=116764589

The key players in the global market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMerieux (France), Bio-Rad (US), and Roche (Switzerland).

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com